Information about COVID-19
Keeping people with epilepsy safe during the Covid-19 pandemic
French et al, Neurology, April 2020
COVID-19 and Epilepsy: More resources from ILAE for patients, clinicians and researchers
Epilepsia en atención primaria para América Latina 20202
Convocatoria ALADE: Curso virtual
Divulgação Curso Virtual Epilepsia no nível de atenção primária à saúde - Portuguese
10 August - 4 October 2020
Período de inscripción: 1 June - 1 August 2020
Epilepsy for Primary Care Online Course - 2020 (English)
The ILAE - Latin America region comprises South and Middle America and Mexico where Spanish and Portuguese are the main languages spoken. Within the framework and according to the strategic plan of the central ILAE, the goal of the ILAE-Latin America is to serve as a regional resource for current and emerging knowledge on epilepsy prevention, diagnosis, treatment, and research.
Current efforts of the ILAE-Latin America are focused on the development of national epilepsy programs and laws and telemedicine projects in the region. In the field of education, courses are being organized for the primary health level as well as specialized epilepsy care.
As the region is extremely heterogeneous, an effort is being made to provide equal learning opportunities for health professionals in rich and poor countries and areas. Guidelines and seminal scientific articles that are available only in English are being translated into Spanish and Portuguese to increase access to knowledge.
Latinoamerica presente en las premiaciones del 33avo Congreso International de Epilepsia
Latin American Awards at the 33rd International Epilepsy Congress
Elections for ALADE
ILAE-Latin America announces the new members of the ALADE Task Force, effective April 2019. See Commission and Task Force Members.
Please take a few minutes to complete the new survey and share it with your colleagues. The survey looks at current treatment practices in 6 typical early life epilepsy scenarios. Our aim is not only to show first and second line treatment preferences, but also to illustrate that we commonly use off-label drugs in childhood epilepsies.
9 September, 2020
More than one-third of people with chronic epilepsy in rural China have potentially epileptogenic lesions identifiable on brain MRI, with two-thirds fulfilling the definition of pharmacoresistance. These findings highlight the magnitude of the unmet needs for epilepsy surgery in China.
17 September, 2020
This paper reviews recent evidence from human and experimental models of absence seizures and concludes that “Together, these novel clinical and experimental findings bring about paradigm-shifting views of our understanding of absence seizures and demand careful choice of initial monotherapy and continuous neuropsychiatric evaluation of affected children”
31 August, 2020
Patients diagnosed with PNES have a SMR 2.5 times above the general population, dying at a rate comparable to those with drug-resistant epilepsy. This emphasizes the importance of prompt diagnosis, identification of risk factors, and implementation of appropriate strategies to prevent potential avoidable deaths.
24 August, 2020
It is with great sadness that IBE announces the death of its esteemed Treasurer, Anthony Mulenga Zimba. A victim of COVID-19, Anthony passed away in hospital in Lusaka, Zambia, on the morning of Sunday 9th August. Anthony had a long history of service to IBE, He worked tirelessly on behalf of people with epilepsy and those who care for them. His particular focus was on his beloved Africa and, as a result of his efforts, many IBE chapters in the region were supported through the IBE Promising Strategies Program in a range of projects aimed at improving their quality of life through training, advocacy and employment opportunities.
11 August, 2020
Subscribe to the ILAE Newsletter
To subscribe, please click on the button below.
Please send me information about ILAE activities and other
information of interest to the epilepsy community